Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026)
Assembly Biosciences (ASMB) posted quarterly Non Operating Income of $2.3 million for Q1 2026, up 104.01% year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $2.3 million in Q4 2025.
Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026) Analysis & Trends
Assembly Biosciences' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 104.01% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $7.2 million (up 42.03% YoY), while the FY2025 annual figure was $6.0 million, up 7.59% from the prior year.
- Non Operating Income for Q1 2026 stood at $2.3 million, roughly flat from $2.3 million in the prior quarter.
- The five-year high for Non Operating Income was $2.3 million in Q4 2025, with the low at $71000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $1.1 million (2024), against an average of $1.1 million.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income jumped 757.75% in 2023, then sank 38.57% in 2025.
- Assembly Biosciences' Non Operating Income stood at $583000.0 in 2022, then surged by 178.22% to $1.6 million in 2023, then tumbled by 30.89% to $1.1 million in 2024, then soared by 104.37% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
- Business Quant data shows ASMB's Non Operating Income at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 2.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 895,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 628,000.00 |
| Jun 30, 2023 | 592,000.00 |
| Mar 31, 2023 | 609,000.00 |
| Dec 31, 2022 | 583,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | 72,000.00 |